Compare Neurocrine Biosciences Inc (NBIX) vs Sezzle Inc (SEZL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Sezzle Inc — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Sezzle Inc trades at $179.07 (market cap $5.78B). The key difference: Neurocrine Biosciences Inc is far larger — about 3× Sezzle Inc's market cap. Which is the better fit depends on your goals.
| NBIX | SEZL | |
|---|---|---|
Market Cap | $17.40B | $5.78B |
Sector | Health | Technology |
52-Week High | $180.55 | $188.55 |
52-Week Low | $123.10 | $50.97 |
Enterprise Value | $16.49B | $5.80B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Sezzle Inc
Sezzle Inc is a financial technology company that operates a Buy Now, Pay Later (BNPL) payment platform. The company allows consumers to make purchases and split the total cost into four interest-free payments over six weeks, primarily serving the e-commerce retail market. Sezzle focuses on promoting financial empowerment by offering a transparent and responsible payment solution to customers at the point of sale.
Read more on SEZL →
